What does CUSIP 28617K101 represent in this 13F holders report?

CUSIP 28617K101 is the security identifier for ELDN - Eledon Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ELDN - Eledon Pharmaceuticals, Inc. - Common Stock in Q2 2022?

27 institutional investors reported ELDN - Eledon Pharmaceuticals, Inc. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Eledon Pharmaceuticals, Inc. - Common Stock (ELDN)

CUSIP: 28617K101

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 75,532,017
Total 13F shares: 6,534,650
Share change: -470,317
Total reported value: $15,944,119
Put/Call ratio: 0%
Price per share: $2.44
Number of holders: 27
Value change: -$1,242,145
Number of buys: 4
Number of sells: 14

Quarterly Holders Quick Answers

What is CUSIP 28617K101?
CUSIP 28617K101 identifies ELDN - Eledon Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 28617K101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BVF INC/IL	13F	Company	3.1%	2,326,710	$9,167,000	—	31 Mar 2022	13F
Cormorant Asset Management, LP	13F	Company	1.7%	1,305,095	$5,142,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	0.9%	679,243	$2,676,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	0.89%	673,138	$2,652,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.74%	555,895	$2,190,000	—	31 Mar 2022	13F
Ikarian Capital, LLC	13F	Company	0.48%	362,537	$1,429,000	—	31 Mar 2022	13F
CM Management, LLC	13F	Company	0.3%	225,000	$887,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.17%	126,710	$499,000	—	31 Mar 2022	13F
Eversept Partners, LP	13F	Company	0.15%	114,008	$449,192	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.11%	84,011	$331,000	—	31 Mar 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.1%	77,100	$304,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.09%	68,486	$270,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	0.08%	59,547	$235,000	—	31 Mar 2022	13F
JMAC ENTERPRISES LLC	13F	Company	0.07%	54,538	$215,000	—	31 Mar 2022	13F
INGALLS & SNYDER LLC	13F	Company	0.07%	51,149	$202,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.06%	44,692	$176,000	—	31 Mar 2022	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.05%	34,630	$136,000	—	31 Mar 2022	13F
Veritable, L.P.	13F	Company	0.04%	33,092	$130,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.04%	30,053	$118,000	—	31 Mar 2022	13F
BAILARD, INC.	13F	Company	0.04%	27,600	$109,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.02%	18,473	$73,000	—	31 Mar 2022	13F
ENVESTNET ASSET MANAGEMENT INC	13F	Company	0.02%	16,726	$66,000	—	31 Mar 2022	13F
MERCER GLOBAL ADVISORS INC /ADV	13F	Company	0.02%	16,726	$66,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	11,951	$47,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0%	1,741	$7,000	—	31 Mar 2022	13F
SIMPLEX TRADING, LLC	13F	Company	0%	1,671	$6,000	—	31 Mar 2022	13F
Rockefeller Capital Management L.P.	13F	Company	0%	1,666	$6,000	—	31 Mar 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,326	$5,000	—	31 Mar 2022	13F
Spire Wealth Management	13F	Company	0%	850	$3,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	0%	603	$2,000	—	31 Mar 2022	13F
IFP Advisors, Inc	13F	Company	0%	1	$1,000	—	31 Mar 2022	13F

Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock (ELDN) as of Q2 2022

As of 30 Jun 2022, Eledon Pharmaceuticals, Inc. - Common Stock (ELDN) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,534,650 shares. The largest 10 holders included BVF INC/IL, Cormorant Asset Management, LP, VANGUARD GROUP INC, Woodline Partners LP, Point72 Asset Management, L.P., Ikarian Capital, LLC, CM Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Ensign Peak Advisors, Inc, and Eversept Partners, LP. This page lists 27 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-3

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.